Cited by 266Substance Abuse Treatment and OutcomesSchizophrenia research and treatmentForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Methamphetamine Psychosis: Epidemiology and Management

Open access

Glasner-Edwards, Suzette, Mooney, Larissa J.·2014·CNS Drugs

DOI 10.1007/s40263-014-0209-8PMC PMC5027896

Open this paper in CoChat — free account

Abstract

Psychotic symptoms and syndromes are frequently experienced among individuals who use methamphetamine, with recent estimates of up to approximately 40 % of users affected. Although transient in a large proportion of users, acute symptoms can include agitation, violence, and delusions, and may require management in an inpatient psychiatric or other crisis intervention setting. In a subset of individuals, psychosis can recur and persist and may be difficult to distinguish from a primary psychotic disorder such as schizophrenia. Differential diagnosis of primary vs. substance-induced psychotic disorders among methamphetamine users is challenging; nevertheless, with careful assessment of the temporal relationship of symptoms to methamphetamine use, aided by state-of-the art psychodiagnostic assessment instruments and use of objective indicators of recent substance use (i.e., urine toxicology assays), coupled with collateral clinical data gathered from the family or others close to the individual, diagnostic accuracy can be optimized and the individual can be appropriately matched to a plan of treatment. The pharmacological treatment of acute methamphetamine-induced psychosis may include the use of antipsychotic medications as well as benzodiazepines, although symptoms may resolve without pharmacological treatment if the user is able to achieve a period of abstinence from methamphetamine. Importantly, psychosocial treatment for methamphetamine dependence has a strong evidence base and is the optimal first-line treatment approach to reducing rates of psychosis among individuals who use methamphetamines. Prevention of methamphetamine relapse is the most direct means of preventing recurrence of psychotic symptoms and syndromes. Long-term management of individuals presenting with recurrent and persistent psychosis, even in the absence of methamphetamine use, may include both behavioral treatment to prevent resumption of methamphetamine use and pharmacological treatment targeting psychotic symptoms. In addition, treatment of co-occurring psychiatric disorders including depression and anxiety is important as a means of preventing relapse to methamphetamine use, which is often triggered by associated symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40263-014-0209-8

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
National Institute of Mental Health Diagnostic Interview Schedule: Its History, Characteristics, and Validity
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
The Composite International Diagnostic Interview: An Epidemiologic Instrument Suitable for Use in Conjunction With Different Diagnostic Systems and in Different Cultures
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
Leucht, S., Pitschel‐Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 795
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535
Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime (UNODC), Vienna.
Gerra, G. (2013) · Cited by 529
Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502
Addictions: A Comprehensive Guidebook
McCrady, B. S., & Epstein, E. E. (2013) · Cited by 488
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
DIXON, L. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00161-3 · Cited by 472
Psychiatric Symptoms in Methamphetamine Users
Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M. Y., & Methamphetamine Treatment Project (2004) · American Journal on Addictions · doi:10.1080/10550490490436055 · Cited by 469
Comorbidity between substance use disorders and psychiatric conditions.
Schuckit, M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01592.x · Cited by 434
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393
A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence
Rawson, R. A., Marinelli‐Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., et al. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00707.x · Cited by 387
The Experimental Reproduction of Amphetamine Psychosis
Bell, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200010020003 · Cited by 357
Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1195 · Cited by 332
Comparison of Amphetamine Psychosis and Schizophrenia
Bell, D. S. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.477.701 · Cited by 328
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295
Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
Sato, M., Chen, C.-C., Akiyama, K., & Otsuki, S. (1983) · PubMed · Cited by 283
Clinical Features of Sensitization to Methamphetamine Observed in Patients with Methamphetamine Dependence and Psychosis
Ujike, H., & Sato, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.035 · Cited by 281
Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis
Brown, M. E., Anton, R. F., Malcolm, R. J., & Ballenger, J. C. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90023-6 · Cited by 273
Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden
Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00114-6 · Cited by 261 · cited 1×
“In addition, individuals with underlying primary psychotic disorders have substantially higher rates of illicit drug use, including amphetamines [50, 51].”
Background
The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia
Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033464 · Cited by 253
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
Bramness, J. G., Gundersen, Ø. H., Guterstam, J., Rognli, E. B., Konstenius, M., Løberg, E., Medhus, S., Tanum, L., & Franck, J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-221 · Cited by 244
Methamphetamine-Associated Psychosis
Grant, K. M., LeVan, T. D., Wells, S. M., Li, M., Stoltenberg, S. F., Gendelman, H. E., Carlo, G., & Bevins, R. A. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9288-1 · Cited by 235
Bupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234
Differences Between Early-Phase Primary Psychotic Disorders With Concurrent Substance Use and Substance-Induced Psychoses
Caton, C. L. M., Drake, R. E., Hasin, D. S., Domínguez, B., Shrout, P. E., Samet, S., & Schänzer, W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.137 · Cited by 232
Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users: Evidence From a Prospective Longitudinal Study
McKetin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.283 · Cited by 221
Cognitive-behavioral therapy for medication-resistant psychosis: A meta-analytic review
Burns, A. M. N., Erickson, D. H., & Brenner, C. A. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300213 · Cited by 199
American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2000
MUNOZ, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/ajp.159.6.1066 · Cited by 189
Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study
McKetin, R., Lubman, D. I., Najman, J. M., Dawe, S., Butterworth, P., & Baker, A. (2014) · Addiction · doi:10.1111/add.12474 · Cited by 183
Substance Abuse by Youth and Young Adults in Rural America
Lambert, D., Gale, J. A., & Hartley, D. (2008) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2008.00162.x · Cited by 178
A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence
Tiihonen, J., Kuoppasalmi, K. I., Föhr, J., Tuomola, P., Kuikanmäki, O., Vorma, H., Sokero, P., Haukka, J. K., & Meririnne, E. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.160 · Cited by 178
Mirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial
Colfax, G. N. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.124 · Cited by 175 · cited 1×
“Last, although no medications have been US Food and Drug Administration approved for the treatment of a MA use disorder, several medications have shown preliminary benefit in reducing MA use in some studies, including bupropion [92], naltrexone [96], mirtazapine [97], and methylphenidate [98].”
Background
Methamphetamine Abuse: A Perfect Storm of Complications
Lineberry, T. W., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.77 · Cited by 175
Subtypes of Drug Abuse With Psychosis
Tsuang, M. T. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020013003 · Cited by 161
A Lasting Vulnerability to Psychosis in Patients with Previous Methamphetamine Psychosis
Sato, M. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25965.x · Cited by 158
World Drug Report 2013
United Nations Office on Drugs and Crime (2013) · World drug report · doi:10.18356/d30739c2-en · Cited by 158
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis
Chen, C., Lin, S., Sham, P. C., Ball, D., Loh, E., & Murray, R. M. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30187 · Cited by 156
The neurobiology of Drug and alcohol addiction
(1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90026-4 · Cited by 156
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Harris, D. S., & Batki, S. L. (2000) · American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 153
Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-Dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment
SHOPTAW, S. J., Peck, J. A., Reback, C. J., & Rotheram-Fuller, E. J. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400511 · Cited by 147
Depression Among Methamphetamine Users
Glasner, S. V., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., Mooney, L. J., & Rawson, R. A. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31819db6fe · Cited by 142
Self-citation
Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan
Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., Horita, N., & Kaneko, T. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01541.x · Cited by 135
Psychopathology in methamphetamine-dependent adults 3 years after treatment
GLASNER‐EDWARDS, S., MOONEY, L. J., MARINELLI‐CASEY, P., HILLHOUSE, M., ANG, A., RAWSON, R. A., & THE METHAMPHETAMINE TREATMENT PROJECT CORPORATE AUTHORS (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00081.x · Cited by 128
An Escalating Dose “Binge” Model of Amphetamine Psychosis: Behavioral and Neurochemical Characteristics
Segal, D. S., & Kuczenski, R. T. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02551.1997 · Cited by 122
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Granado, N., Ares‐Santos, S., Oliva, I., O’Shea, E., Martín, E. D., Colado, M. I., & Moratalla, R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.033 · Cited by 118
Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration
Matsumoto, T., Kamijo, A., Miyakawa, T., Endo, K., Yabana, T., Kishimoto, H., Okudaira, K., Iseki, E., Sakai, T., & Kosaka, K. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00143.x · Cited by 113
Amphetamine Poisoning
Espelin, D. E., & Done, A. K. (1968) · New England Journal of Medicine · doi:10.1056/nejm196806202782502 · Cited by 112
Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence
Jayaram‐Lindström, N., Konstenius, M., Eksborg, S., Beck, O., Hammarberg, A., & Franck, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301572 · Cited by 107
The risk of psychotic symptoms associated with recreational methamphetamine use
McKetin, R., HICKEY, K., Devlin, K., & LAWRENCE, K. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00160.x · Cited by 99
Long‐term outcomes in methamphetamine psychosis patients after first hospitalisation
Kittirattanapaiboon, P., Mahatnirunkul, S., Booncharoen, H., THUMMAWOMG, P., DUMRONGCHAI, U., & Chutha, W. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00196.x · Cited by 98
Longitudinal Clinical Course Following Pharmacological Treatment of Methamphetamine Psychosis Which Persists after Long‐Term Abstinence
Akiyama, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.012 · Cited by 86
Amphetamine-Type Stimulants
Rasmussen, N. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.001 · Cited by 80
Clinical course and outcomes of methamphetamine-dependent adults with psychosis
Glasner, S. V., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., & Rawson, R. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.004 · Cited by 76
Self-citation
Six-Month Outcomes for Patients Who Switched to Olanzapine Treatment
Noordsy, D. L., O’Keefe, C. D., Mueser, K. T., & Xie, H. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.501 · Cited by 75
Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
McConville, B. J., & Sorter, M. T. (2004) · PubMed · Cited by 74
Treatment for amphetamine psychosis
SHOPTAW, S. J., Kao, U. H., & Ling, W. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003026.pub3 · Cited by 72
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross‐sectional study
Ringen, P. A., Melle, I. S., Birkenaes, A. B., Engh, J. A., Færden, A., Jónsdóttir, H., Nesvåg, R., Vaskinn, A., Friis, S., Larsen, F., et al. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01135.x · Cited by 71
Remission of Persistent Methamphetamine-Induced Psychosis After Electroconvulsive Therapy: Presentation of a Case and Review of the Literature
Grelotti, D. J., Kanayama, G., & Pope, H. G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111695 · Cited by 67
Duration effects in contingency management treatment of methamphetamine disorders
Roll, J. M., Chudzynski, J., Cameron, J. M., Howell, D. N., & McPherson, S. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.018 · Cited by 65
Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers
Shaner, A. L., Roberts, L. J., Eckman, T. A., Racenstein, J. M., Tucker, D. E., TSUANG, J. W., & Mintz, J. (1998) · Psychiatric Services · doi:10.1176/ps.49.5.684 · Cited by 65
Tardive Dyskinesia in Psychiatric Patients with Substance Use Disorders
vera, A. A. O., Kiefer, M. M., & Manley, N. K. (1990) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999009001572 · Cited by 64
Amphetamines and Related Stimulants: Chemical, Biological, Clinical, and Sociological Aspects
(2019) · CRC Press eBooks · doi:10.1201/9780429279843 · Cited by 62
A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards
Medhus, S., Mordal, J., Holm, B., Mørland, J. G., & Bramness, J. G. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.023 · Cited by 57
The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia
Sulaiman, A. H., Said, M. A., Habil, M. H., Rashid, R. B. A., Nordin, A. S. A., Ng, C. G., Midin, M., Jaafar, N. R. N., Sidi, H., & Das, S. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.01.003 · Cited by 57
Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.
Batki, S., & Harris, D. (2004) · American Journal on Addictions · doi:10.1080/10550490490512834 · Cited by 56
Olanzapine Treatment of Methamphetamine Psychosis
Misra, L. K., Kofoed, L., Oesterheld, J. R., & Richards, G. A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00023 · Cited by 53
Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine
Verachai, V., Rukngan, W., Chawanakrasaesin, K., Nilaban, S., Suwanmajo, S., Thanateerabunjong, R., Kaewkungwal, J., & Kalayasiri, R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3485-6 · Cited by 52
Chronic Schizophrenia‐Like States in Methamphetamine Psychosis
Tomiyama, G. (1990) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1990.tb01626.x · Cited by 47
Unanswered Questions Regarding Atypical Antipsychotic Use in Aggressive Children and Adolescents
Patel, N. C., Crismon, M. L., Hoagwood, K., & Jensen, P. S. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.270 · Cited by 46
A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis.
Leelahanaj, T., Kongsakon, R., & Netrakom, P. (2005) · PubMed · Cited by 45
A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence
Tiihonen, J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.1.160 · Cited by 43
Mania Following Sleep Deprivation
Wright, J. B. D. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.5.679 · Cited by 41
Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia
Vincent, N. C., Shoobridge, J., Ask, A., ALLSOP, S. J., & Ali, R. L. (1998) · Drug and Alcohol Review · doi:10.1080/09595239800186991 · Cited by 38
Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting.
Noordsy, D. L., & O’Keefe, C. D. (1999) · PubMed · Cited by 38
Diagnosing comorbidity: concepts, criteria, and methods
Samet, S., Nunes, E. V., & Hasin, D. S. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2004.0062.x · Cited by 37
When Acute-Stage Psychosis and Substance Use Co-Occur: Differentiating Substance-Induced and Primary Psychotic Disorders
Caton, C. L. M., Samet, S., & Hasin, D. S. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200009000-00006 · Cited by 36
Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey.
Sato, M. (1986) · PubMed · Cited by 36
Chronic Methamphetamine Psychosis after Long-Term Abstinence in Japanese Incarcerated Patients
Akiyama, K., Saito, A., & Shimoda, K. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00124.x · Cited by 35
Risperidone treatment of methamphetamine psychosis
Misra, L., & Kofoed, L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1170a · Cited by 32
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
Yui, K., Goto, K., Ikemoto, S., Nishijima, K., Yoshino, T., & Ishiguro, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00240-4 · Cited by 31
Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
Yui, K., Goto, K., Ikemoto, S., & Ishiguro, T. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00060-5 · Cited by 30
A Rating Scale for Evaluation of the Clinical Course and Symptomatology in Amphetamine Psychosis
Jönsson, L. E., & Sjöström, K. (1970) · The British Journal of Psychiatry · doi:10.1192/bjp.117.541.661 · Cited by 19
Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse
Salo, R. E., NORDAHL, T. E., Leamon, M. H., Natsuaki, Y., Moore, C. D., Waters, C., & Carter, C. S. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.04.018 · Cited by 18
Methamphetamine Psychosis in Japan: a survey
Nakatani, Y., Yoshizawa, J., Yamada, H., Iwanami, A., Sakaguchi, M., & Katoh, N. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03941.x · Cited by 17
Haloperidol Treatment after High-Dose Methamphetamine Administration Is Excitotoxic to GABA Cells in the Substantia Nigra Pars Reticulata
Hatzipetros, T., Raudensky, J., Soghomonian, J., & Yamamoto, B. K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5260-06.2007 · Cited by 17
[Relationship between years of methamphetamine use and symptoms of methamphetamine psychosis].
Wada, K., & Fukui, S. (1990) · PubMed · Cited by 16
Schizophreniform Psychosis Induced by Large-Dose Administration ofd-Amphetamine
Griffith, J. D., Cavanaugh, J. H., & Oates, J. (1969) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1969.10524411 · Cited by 16
Overdiagnosis of schizophrenia: role of alcohol and drug misuse
Cohen, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92058-7 · Cited by 15
Guidelines for the medical management of patients with methamphetamine-induced psychosis
Mclver, C., McGregor, C., Baigent, M. F., Spain, D. J., Newcombe, D. A. L., & Ali, R. L. (2006) · Cited by 15
Methamphetamine Use
McPherson, S., Hall, H. V., Hall, H. V., & Yudko, E. B. (2003) · CRC Press eBooks · doi:10.1201/9780203503782 · Cited by 13
Substance-Induced Psychosis.
Bacon, A., Granholm, E. L., & Withers, N. (1998) · PubMed · Cited by 12
In Reply:
(2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200009000-00003 · Cited by 10

Flagged first, then by citations

Research works printed but not linked: 6

World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Geneva: Diagnostic Criteria For Research; 1992.
Connell PH. Amphetamine psychosis. Maudsley Monograph No. 5, London: Oxford University Press; 1958.
Volkow ND. NIDA research report: methamphetamine abuse and addiction. Washington: National Institute on Drug Abuse; 2006.
Wada K, Fukui S. Residual symptoms in methamphetamine psychosis. J Mental Health. 1991;37:161–8.
First MB, Spitzer RL, Williams JEW, et al. Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV) (User’s guide and interview). Washington, DC: American Psychiatric Press; 1997.
Rawson RA. Methamphetamine: new knowledge, new treatments. Center City, MN: Hazelden; 2006.

Sorted by citations

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00711-x · Cited by 194
Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis
Chan, B., Freeman, M., Kondo, K., Ayers, C., Montgomery, J., Paynter, R., & Kansagara, D. (2019) · Addiction · doi:10.1111/add.14755 · Cited by 160
A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology
Wearne, T. A., & Cornish, J. L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00491 · Cited by 144
A systematic review of risk factors for methamphetamine-associated psychosis
Arunogiri, S., Foulds, J., McKetin, R., & Lubman, D. I. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417748750 · Cited by 118
Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors
Shin, E., Dang, D., Tran, T.-V., Tran, H., Jeong, J. H., Nah, S.-Y., Jang, C., Yamada, K., Nabeshima, T., & Kim, H. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0897-y · Cited by 106

See all 266

Authors: Glasner-Edwards, S., & Mooney, L. J.
Affiliations: University of California, Los Angeles (US)
ORCID: Mooney, Larissa J.
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2014-11-06
Volume: 28
Issue: 12
Pages: 1115-1126
ISSN: 1172-7047 (ISSN-L)
1179-1934
DOI: 10.1007/s40263-014-0209-8
PMC: PMC5027896
OpenAlex: W2035893127
Cited by: 266
References: 97
Citations by year: 2026: 26 · 2025: 28 · 2024: 29 · 2023: 34 · 2022: 31 · 2021: 31 · 2020: 18 · 2019: 19 · 2018: 26 · 2017: 9 · 2016: 12 · 2015: 2 · 2014: 1
FWCI: 6.04
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (K23DA020085)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: methamphetamine psychosis, drug-induced psychosis, differential diagnosis, schizophrenia, antipsychotic drugs, benzodiazepines, methamphetamine dependence, psychosocial interventions, relapse prevention, urine toxicology, crisis intervention
MeSH terms: Central Nervous System Stimulants, Humans, Methamphetamine, Psychoses, Substance-Induced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Methamphetamine Psychosis: Epidemiology and Management

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks